| Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits GG Rossetti, MA Ossorio, S Rempel, A Kratzel, VS Dionellis, S Barriot, ... Scientific reports 12 (1), 2505, 2022 | 45 | 2022 |
| Mitotic DNA synthesis is caused by transcription-replication conflicts in BRCA2-deficient cells FJ Groelly, RA Dagg, M Petropoulos, GG Rossetti, B Prasad, ... Molecular Cell 82 (18), 3382-3397. e7, 2022 | 22 | 2022 |
| Enhanced rate of acquisition of point mutations in mouse intestinal adenomas compared to normal tissue N Lugli, VS Dionellis, P Ordóñez-Morán, I Kamileri, SK Sotiriou, ... Cell reports 19 (11), 2185-2192, 2017 | 22 | 2017 |
| Notch controls urothelial integrity in the mouse bladder V Paraskevopoulou, V Bonis, VS Dionellis, N Paschalidis, P Melissa, ... JCI insight 5 (3), 2020 | 12 | 2020 |
| Genome Sequencing of five Lacticaseibacillus Strains and Analysis of Type I and II Toxin-Antitoxin System Distribution A Levante, C Lazzi, G Vatsellas, D Chatzopoulos, VS Dionellis, ... Microorganisms 9 (3), 648, 2021 | 9 | 2021 |
| Cdt1 overexpression drives colorectal carcinogenesis through origin overlicensing and DNA damage M Petropoulos, S Champeris Tsaniras, S Nikou, S Maxouri, VS Dionellis, ... The Journal of Pathology 259 (1), 10-20, 2023 | 5 | 2023 |
| Genomic instability profiles at the single cell level in mouse colorectal cancers of defined genotypes VS Dionellis, M Norkin, A Karamichali, GG Rossetti, J Huelsken, ... Cancers 13 (6), 1267, 2021 | 4 | 2021 |
| Identification of low micromolar SARS-CoV-2 Mpro inhibitors from hits identified by in silico screens GG Rossetti, M Ossorio, S Barriot, L Tropia, VS Dionellis, C Gorgulla, ... bioRxiv, 2020.12. 03.409441, 2020 | 2 | 2020 |
| Beating cancer one carbon at a time VS Dionellis, TD Halazonetis Nature Cancer 3 (2), 141-142, 2022 | 1 | 2022 |
| Transcription–replication conflicts underlie sensitivity to PARP inhibitors M Petropoulos, A Karamichali, GG Rossetti, A Freudenmann, LG Iacovino, ... Nature 628 (8007), 433-441, 2024 | | 2024 |
| FoRx-06-428 is a novel PARG inhibitor with potent anti-tumor efficacy in preclinical cancer models O Querolle, U Lücking, L Iacovino, A Freudenmann, G Rossetti, M Gysin, ... Cancer Research 84 (6_Supplement), 3366-3366, 2024 | | 2024 |
| Insights into DNA Damage in Regenerating Young and Aged Mouse Livers A Asensio Aldave, N Dommann, G Rossetti, A Karamichali, V Dionellis, ... British Journal of Surgery 110 (Supplement_5), znad178. 007, 2023 | | 2023 |
| DNA damage generated by transcription-replication conflicts explains the synthetic lethality of PARP inhibitors with homologous recombination deficiency TD Halazonetis, M Petropoulos, GG Rossetti, A Karamichali, ... Cancer Research 83 (7_Supplement), 1566-1566, 2023 | | 2023 |
| Genomic Instability Profiles at the Single Cell Level in Mouse Colorectal Cancers of Defined Genotypes. Cancers 2021, 13, 1267 VS Dionellis, M Norkin, A Karamichali, GG Rossetti, J Huelsken, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| Mapping origins of replication in a regenerating liver post partial hepatectomy G Rossetti, N Dommann, A Karamichali, V Dionellis, A Keogh, ... Journal of Hepatology 73, S112, 2020 | | 2020 |
| Identification of low micromolar SARS-CoV-2 Mpro inhibitors from hits identified by in silico screens (preprint) GG Rossetti, M Ossorio, S Barriot, L Tropia, VS Dionellis, C Gorgulla, ... | | 2020 |
